vimarsana.com

Latest Breaking News On - Chromiumx series - Page 2 : vimarsana.com

10x Genomics, Inc - Consensus buy rating and 21 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 21.0% Upside Potential

Paylocity holding corporationGenomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

10x Genomics, Inc - Consensus buy rating and 71 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 71.0% Upside Potential

Genomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

Chromium x Series

The Chromium x Series lets you access single cell analysis at any stage. flexibility, connectivity, scalable upgrades

Genomics cloudChromiumx series10x genomics

10x Genomics, Inc - Consensus buy rating and 12 7% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 12.7% Upside Potential

Genomics incPaylocity holding corporationChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

10x Genomics Reports Second Quarter 2023 Financial Results

/PRNewswire/ 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended.

Hong kongUnited statesSerge saxonovGenomics incExchange commissionSecurities exchangeVisium cytassist geneProtein expressionChromiumx seriesConference callPrivate securities litigation reform actSecurities actSecurities exchange actFinancial conditionConsolidated statementsMiddle east

vimarsana © 2020. All Rights Reserved.